5849results about How to "Inhibit growth" patented technology

A heat treatment jig for supporting silicon semiconductor substrates by contacting, being loaded onto a heat treatment boat in a vertical heat treatment furnace, comprises; the configuration of a ring or a disc structure with the wall thickness between 1.5 and 6.0 mm; the deflection displacement of 100 μm or less at contact region in loaded condition; the outer diameter which is 65% or more of the diameter of said substrate; and the surface roughness (Ra) of between 1.0 and 100 μm at the contact region. The use of said jig enables to effectively retard the slip generation and to avoid the growth hindrance of thermally oxidized film at the back surface of said substrate, diminishing the surface steps causing the defocus in photolithography step in device fabrication process, thereby enabling to maintain high quality of silicon semiconductor substrates and to substantially enhance the device yield.

Isolated human monoclonal antibodies which specifically bind to human EGFR, and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced by a transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.

An activatable (e.g., heat expandable) material and articles incorporating the same is disclosed. The material includes an epoxy resin; an epoxy/elastomer hybrid or reaction product; a blowing agent; a curing agent; and optionally, a filler. In preferred embodiments, the material includes aramid fiber, nanoclay or both.

The present invention relates to the isolation and characterization of nucleotide sequences encoding novel insecticidal proteins secreted into the extracellular space from Bacillus thuringiensis and related strains. The proteins are isolated from culture supernatants of Bacillus thuringiensis and related strains and display insecticidal activity against coleopteran insects including Colorado potato beetle (Lymantria dispar) and Southern Corn Rootworm (Diabrotica undecempunctata). Insecticidal proteins encoded by nucleotide sequences that hybridize to the isolated and characterized nucleotide sequences are disclosed. Also disclosed are methods of making and using transgenic cells and plants comprising the novel nucleotide sequence of the invention.

Methods for preventing or treating an IgE-mediated allergic disease in a patient are presented, the methods comprising administration of a monoclonal antibody capable of binding to a human CD40 antigen located on the surface of a human B cell, wherein binding of the antibody to the CD40 antigen prevents the growth or differentiation of the B cell. Monoclonal antibodies useful in these methods, and epitopes immunoreactive with such monoclonal antibodies are also presented.

A biofilm penetrating composition for coating medical devices for substantially preventing the growth or proliferation of biofilm embedded microorganisms on at least one surface of the medical device is disclosed. A biofilm penetrating composition solution for cleaning medical devices which is capable of substantially removing all of the biofilm embedded microorganisms from at least one surface of medical devices is also disclosed. The biofilm penetrating composition coating and solution include a biofilm penetrating agent and may also include a base material. Medical devices coated with the biofilm penetrating composition and methods for coating medical devices and methods for removing biofilm embedded microorganisms from at least one surface of the medical devices are also disclosed.

The present invention relates to a pharmaceutical combination for the treatment of diseases which involves cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis. The invention also relates to a method for the treatment of said diseases, comprising co-administration of effective amounts of specific active compounds and/or co-treatment with radiation therapy, in a ratio which provides an additive and synergistic effect, and to the combined use of these specific compounds and/or radiotherapy for the manufacture of corresponding pharmaceutical combination preparations.

The present invention relates to oil-in-water mascara compositions comprising water-insoluble polymeric materials in the form of an aqueous emulsion, water-soluble, film-forming polymers and organophilic clays. Said compositions exhibit improved wear and are removable with soap and water.

In certain aspects, the present invention provides compositions and methods for decreasing FSH levels in a patient. The patient may, for example, be diagnosed with an FSH-related disorder or desire to delay or inhibit germ cell maturation.

The present disclosure provides polypeptide heterodimers formed between two different single chain fusion polypeptides via natural heterodimerization of an immunoglobulin CH1 region and an immunoglobulin light chain constant region (CL). One chain of a heterodimer comprises a binding domain that specifically binds a target (e.g., a receptor). In addition, both chains of a heterodimer further comprise an Fc region portion. The present disclosure also provides nucleic acids, vectors, host cells and methods for making polypeptide heterodimers as well as methods for using such polypeptide heterodimers, such as in reducing T cell activation, inhibiting solid malignancy growth, and treating autoimmune or inflammatory conditions.

The present invention generally relates to articles of manufacture, such as medical devices, having a non-fouling surface comprising a grafted polymer material. The surface resists the adhesion of biological material.

Recombinant immunotoxins are fusion proteins composed of the Fv domains of antibodies fused to bacterial or plant toxins. RFB4 (Fv)-PE38 is an immunotoxin that targets CD22 expressed on B cells and B cell malignancies. The present invention provides antibodies and antibody fragments that have improved ability to bind the CD22 antigen compared to RFB4. Immunotoxins made with the antibodies and antibody fragments of the invention have improved cytotoxicity to CD22-expressing cancer cells. Compositions that incorporate these antibodies into chimeric immunotoxin molecules that can be used in medicaments and methods for inhibiting the growth and proliferation of such cancers. Additionally, the invention provides a method of increasing the cytotoxicity of forms of Pseudomonas exotoxin A (“PE”) with the mutation of a single amino acid, as well as compositions of such mutated PEs, nucleic acids encoding them, and methods for using the mutated PEs.

Methods and devices arising from the practice thereof for making and using battery electrodes formed onto ion permeable, electrically non-conductive substrates, preferably battery separators are disclosed herein. Electrodes are formed onto substrates using a variety of methods including, but not limited to, spray coating and electrophoretic deposition. Electrically conductive layers may be applied to the electrode coating layer side opposite or adjacent to the substrate to act as current collectors for the battery. Multilayer devices having alternating layers of conductive layers, electrode layers and substrates, wherein the conductive layers may be in electrical communication with other conductive layers to form a battery.

The invention belongs to the field of titanium-based alloys, and particularly relates to a novel heat-resisting titanium alloy and a processing and manufacturing method and application thereof. The processing and manufacturing method comprises the composition elements of alloy components, smelting, heat processing, heat treatment and the like, wherein the alloy components are as follows (in percentage by weight): 5.4%-6.3% of Al, 3.0%-5.0% of Sn, 2.5%-6.4% of Zr, 0.0%-0.96% of Mo, 0.25%-0.5% of Si, 0.2%-0.5% of Nb, 0.3%-3.4% of Ta, 0.2%-1.6% of W, 0.0%-0.07% of C, less than or equal to 0.17% of O, less than or equal to 0.03% of Fe and the balance of Ti and inevitable impurity elements. The novel heat-resisting titanium alloy disclosed by the invention can obtain different matching of tensile strength, plasticity, permanence, creep strength and heat stability through the combination of different heat processing process and heat treatment processes, can be used for manufacturing parts, namely blades, coil assemblies and the like which are positioned on the high-temperature parts of an advanced aircraft engine, is used for a long time within a range of 600-650 DEG C, can also be used for manufacturing high temperature-resistant structural members, namely aerospace craft skin and the like, is used for a short time at about 700 DEG C and can be used as a material and the like used for high temperature-resistant corrosion-resistant valves of an automobile and a boiler.

A photocatalytically active titanium dioxide film may be applied onto surfaces of a variety of objects to oxidize matter that comes into contact with those surfaces. Various methods may be used to apply a solution of the photocatalytically active nanoparticles onto surfaces receiving regular human contact or proximate to human presence. An inorganic primer layer may be initially applied to an organic substrate, such as food, plants, flowers and foliage, to prevent the photocatalytically active coating from oxidizing the organic substrate.

The present invention relates to methods and compositions for the cryopreservation of pluripotent cells in general and human embryonic stem (ES) cells in particular. The stem cells are grown on a bottom layer of solid support matrix and subsequently covered by a top layer of solid support matrix forming a matrix-cell-matrix composition, to which an effective amount of cryopreservation media is added, prior to freezing. The methods of the invention yield cryopreserved cells that exhibit an increase in cell viability and a decrease in cell differentiation, facilitating storage, shipping and handling of embryonic stem cell stocks and lines for research and therapeutics.

A composition described wherein bismuth is chelated by a complexing agent such as a pyrithione or certain other thiol compounds in the form a metal:complexing agent complex. Methods for using the composition as a bacteriocidal, bacteriostatic, antibiofilm, antifungal, and antiviral agent and as a disinfectant and preservative are also provided.

The invention discloses a preparation method of laser forming nano particle reinforced aluminum-based composite material, belonging to the technical field of particle reinforced aluminum-based composite materials. The method comprises the steps of: (1) selecting SiC powder with purity of more than 99.9% and granularity of 40-60 nanometers, and AlSi10Mg powder with purity of more than 99.9% and granularity of 15-30 micrometers; (2) mixing the powders, wherein the weight of the SiC powder is 3%-10% of the total weight of the mixed powder; (3) putting the mixed powder into a planetary high-energy ball mill for milling; (4) taking the milled powder for SLM forming; and (5) repeating the step (4) until a three-dimensional block sample is completed. According to the method provided by the invention, the aluminum-based composite material with uniform microscopic structures can be prepared.

All or a portion of a surface of an implantable sensor is covered with a biocompatible coating formed at least partially of a biomaterial matrix having properties that promote a substantially even growth of tissue cells over the surface of the coating. Additional materials, such as growth factors, agents that recruit endogenous stem cells, and cell adhesion motif arginine, glycine, aspartic acid may be included in the coating. Autologous cells may be added to the coating prior to implantation. The sensor surface may also be textured, by etching or abrading, in order to promote even tissue growth. Alternatively, the sensor surface may be covered with a coating having properties that inhibit the growth of tissue. These coatings may include a biomaterial, a biomaterial matrix having a drug, such as a sirolimus or a steroid, an active component, or a self assembled monolayer.

The invention discloses a low-welding crack sensitivity steel board and manufacturing method, which comprises the following parts: not more than 0.07% C, 0.15-0.40% Si, 1.00-1.60% Mn, not more than 0.015% P, not more than 0.010% S, not more than 0.30% Cu, not more than 0.50% Ni, not more than 0.30% Cr, not more than 0.30% Mo, not more than 0.08% V, not more than 0.08% Nb, 0.010-0.020% Ti, not more than 0.003% B, Fe and inevitable impurity. The invention is characterized by the following: (1)displaying lower welding crack sensitivity component with Pcm not more than 0.20%; (2)mating the strength and flexibility reasonably with fitful yielding ratio; (3)making the price and property of the steel board superior to the congeneric import product; (4)making the maximum breadth of steel board to 4000mm; (5)simplifying the technique to ensure higher flatness without quenching water.